 LEIDEN, Netherlands CAMBRIDGE, Mass., Dec. 22, 2022 GLOBE NEWSWIRE -- ProQR Therapeutics N.V. Nasdaq: PRQR ProQR, a company dedicated to changing lives through transformative RNA therapies, today announced that ProQR management will host an investor conference call and webcast to discuss the Companys Axiomer RNA editing technology platform following the recently announced partnership expansion with Lilly. ProQR will host the call on December 22, 2022, at 8:15am EST. 